Peripheral T-cell Lymphomas (PTCL)
4 clinical trials · Condition
◉ Watch Peripheral T-cell Lymphomas (PTCL)
| Record | Firm | Date |
|---|---|---|
| Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas (NCT05105412) | National Health Research Institutes, Taiwan | 2022-06-15 |
| Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies (NCT04767308) | Huazhong University of Science and Technology | 2021-03-01 |
| Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas (NCT02223208) | Fondazione Italiana Linfomi - ETS | 2014-09-01 |
Track Peripheral T-cell Lymphomas (PTCL) automatically
Every clearance here is in the API, with alerts when new ones post.